Yong Li
Xiamen University · 25 works · 837 citations · h-index 16
Top works
- Structural Basis for Hydroxycholesterols as Natural Ligands of Orphan Nuclear Receptor RORγ
- Context-aware real-time population estimation for metropolis
- Revealing a Mutant-Induced Receptor Allosteric Mechanism for the Thyroid Hormone Resistance
- Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease
- Selective targeting of PPARγ by the natural product chelerythrine with a unique binding mode and improved antidiabetic potency
- Thyroid hormone resistance: Mechanisms and therapeutic development
- Structural insights into the heterodimeric complex of the nuclear receptors FXR and RXR
- Discovery of a Highly Selective and H435R-Sensitive Thyroid Hormone Receptor β Agonist
- Structural Basis for Iloprost as a Dual Peroxisome Proliferator-activated Receptor α/δ Agonist
- A Novel Class of Natural FXR Modulators with a Unique Mode of Selective Co‐regulator Assembly
- Identification of an Oleanane-Type Triterpene Hedragonic Acid as a Novel Farnesoid X Receptor Ligand with Liver Protective Effects and Anti-inflammatory Activity
- Revealing a steroid receptor ligand as a unique PPARγ agonist
- Theory on optimizing the activity of electrocatalytic proton coupled electron transfer reactions
- Revealing a natural marine product as a novel agonist for retinoic acid receptors with a unique binding mode and inhibitory effects on cancer cells
- AES-CSFS: an automatic evaluation system for corneal sodium fluorescein staining based on deep learning
- A predictive model for postoperative cognitive dysfunction in elderly patients with gastric cancer: a retrospective study.
- Identification of an allosteric hotspot for additive activation of PPARγ in antidiabetic effects
- Structural basis for the hepatoprotective effects of antihypertensive 1,4-dihydropyridine drugs
- Context-Aware Semantic Annotation of Mobility Records
- Discovery of a Potent, Selective, and Multiple His435 Mutation-Sensitive Thyroid Hormone Receptor β Agonist